| AMH | Anti-Mullerian hormone |
| ART | Assisted reproductive techniques |
| BDE-47 | 2,2′,4,4′-tetrabromodiphenyl ether |
| BPA | Bisphenol A |
| DES | Diethylstilbestrol |
| DMRs | Differentially methylated regions |
| DDT | 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane |
| DEHP | Di(2-ethylhexyl) phthalate |
| EE2 | Ethinylestradiol |
| EDCs | Endocrine-disrupting chemicals |
| Endo-siRNAs | Endogenous-small interfering RNAs |
| EVs | Extracellular vesicles |
| FDA | U.S. Food and Drug Administration |
| H3K9me3 | H3K9 trimethylation |
| HAT | Histone acetyltransferase |
| HPTE | 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane |
| Igf2 | Insulin-like growth factor 2 |
| lincRNAs | Large intergenic non-coding RNAs |
| LIF | Leukemia inhibitory factor |
| lncRNA | Long non-coding RNA |
| miRNAs | MicroRNAs |
| mRNA | Messenger RNA |
| MXC | Methoxychlor (1,1,1-trichloro-2,2-bis(p-methoxyphenyl) ethane) |
| NOAEL | No-observed-adverse-effect level |
| OP | Organophosphate |
| OPFRs | Organophosphate flame retardants, |
| piRNAs | Piwi-interacting RNAs |
| PBDEs | Polybrominated diphenyl ethers |
| PAHs | Polycyclic aromatic hydrocarbons |
| PCBs | Polychlorinated biphenyls |
| PCOS | Polycystic ovary syndrome |
| PFOS | Perfluorooctane sulfonate |
| PFOA | Perfluorooctanoate |
| PGC | Primordial germ cells |
| PPAR | Peroxisome proliferator-activated receptor |
| snoRNAs | Small nucleolar RNAs |
| sncRNA | Small non-coding RNAs |
| SUV39H2 | SUppressor of Variegation 3-9 homolog 2 Histone Lysine Methyltransferase |
| TBBPA | Tetrabromobisphenol A |
| TBT | Tributyltin |
| TCDD | 2,3,7,8-tetrachlordibenzo-p-dioxin |
| TPT | Triphenyltin |
| Xist | X-inactive specific transcript |